JACOBSON PHARMA CORPORATION LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.59 HKD | -3.28% |
|
-1.67% | -7.81% |
| 02-27 | Jacobson Pharma Raises HK$39 Million from Share Placement | MT |
| 2023 | Jacobson Pharma Corporation Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jacobson Pharma Corporation Ltd is an investment holding company principally engaged in the manufacturing and sale of generic drugs. The Company operates its business through two segments. The Generic Drugs segment is engaged in the development, manufacture and distribution of a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment is engaged in the development, manufactures and distributes branded medicines, proprietary Chinese medicines and health and wellness products. Currently the activities of two segments in this regard are primarily carried out in Hong Kong.
Sector
Pharmaceuticals
Calendar
24/06/2024
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.81% | 156M | |
| +22.35% | 44.12B | |
| +22.22% | 22.61B | |
| +17.81% | 15.11B | |
| +15.73% | 13.61B | |
| +57.91% | 13.34B | |
| -8.98% | 6.94B | |
| -0.05% | 6.79B | |
| +15.65% | 5.75B | |
| -8.87% | 5.73B |
- Stock Market
- Equities
- 2633 Stock
- News Jacobson Pharma Corporation Limited
- Jacobson Pharma CEO Increases Stake; Shares Rise 3%
